We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Worldwide Sarcoidosis Research Study (WISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01610843
Recruitment Status : Recruiting
First Posted : June 4, 2012
Last Update Posted : March 30, 2017
National Center for Research Resources (NCRR)
Information provided by (Responsible Party):
Alicia Gerke, University of Iowa

Brief Summary:

The aim of this study is to collect information about the clinical course and characteristics of sarcoidosis patients around the world through web-based surveys. Recruitment is directed at and driven by patients in the sarcoidosis community. This will allow the the investigators to study sarcoidosis patients across all demographic, geographic, and socioeconomic boundaries, not just patients seen at large research centers. The investigators believe this study can give investigators a broader and less biased view of sarcoidosis. The investigators would also like to collect genetic samples on this population to assess genetic variance in different phenotypes.

The information for the study would be provided through a web based survey system that can be accessed by patients or physicians of patients from any computer with Internet access. This system would collect clinical information in sufficient detail so that the phenotype of individual patients can be evaluated. Upon agreeing to participate in further research studies through the website, subjects will also have the opportunity to provide a DNA sample.

Condition or disease Intervention/treatment
Sarcoidosis Other: Survey

Study Type : Observational
Estimated Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Worldwide Sarcoidosis Research Study
Study Start Date : December 2011
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sarcoidosis
U.S. FDA Resources

Intervention Details:
    Other: Survey
    Longitudinal surveys

Primary Outcome Measures :
  1. Define and characterize sarcoidosis phenotypes and methods of care [ Time Frame: Anticipated by 2017 ]
    To give a broader and less biased view of sarcoidosis

Biospecimen Retention:   Samples With DNA
Saliva samples will be collected and processed at the University of Iowa.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals diagnosed with sarcoidosis who have a computer with Internet access.

Inclusion Criteria:

  • Diagnosis of Sarcoidosis
  • Access to a computer with Internet

Exclusion Criteria:

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01610843

Contact: Alicia K Gerke, MD 319-356-1869 alicia-gerke@uiowa.edu
Contact: Emily K Phillips, BSN 319-356-1869 emily-phillips@uiowa.edu

United States, Iowa
University of Iowa Recruiting
Iowa City, Iowa, United States, 52242
Contact: Alicia K Gerke, MD    319-356-1869    alicia-gerke@uiowa.edu   
Sub-Investigator: Alicia K Gerke, MD         
Sponsors and Collaborators
University of Iowa
National Center for Research Resources (NCRR)
Principal Investigator: Alicia K Gerke, MD University of Iowa

Additional Information:

Responsible Party: Alicia Gerke, Assistant Professor; Division of Pulmonary, Critial Care and Occupational Medicine, University of Iowa
ClinicalTrials.gov Identifier: NCT01610843     History of Changes
Other Study ID Numbers: 200907757
5UL1RR024979 ( U.S. NIH Grant/Contract )
First Posted: June 4, 2012    Key Record Dates
Last Update Posted: March 30, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Alicia Gerke, University of Iowa:
Sarcoid Study
Worldwide Sarcoidosis Research Study

Additional relevant MeSH terms:
Lymphoproliferative Disorders
Lymphatic Diseases